ANGO vs EXPE · rev $292.5M vs P/E 20, rev $13.69B
AngioDynamics Inc (ANGO) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
ANGO currently screens at market cap $378.5M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the ANGO and EXPE stock pages for the full models.
Not investment advice.